Clinical Trial Update: A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)

View source ↗

Summary

This clinical trial update describes a study to measure how much palopegteriparatide is present in the breast milk of lactating women who require YORVIPATH. Rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• YORVIPATH (palopegteriparatide)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Hypoparathyroidism | Status: RECRUITING